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Abstract
This study evaluated the effect of restrictive filling pattern (RFP) on 5-year outcomes in
patients following ST-segment elevation myocardial infarction (STEMI). A hundred
STEMI patients treated either by rescue or primary percutaneous coronary intervention
with an echocardiogram performed within 6 weeks of STEMI comprised the study
group. Creatinine kinase (CK) and left ventricular ejection fraction were independent
determinants of RFP, and RFP was an independent predictor of cardiac and all-cause
mortality at median follow up of 5 years.
Percutaneous coronary intervention (PCI), for ST-
segment elevation myocardial infarction (STEMI), limits
myocardial injury and reduces mortality;1 however, myo-
cardial damage from STEMI results in systolic and dias-
tolic dysfunction (DD). Although elevated left ventricular
(LV) end-diastolic pressure is a predictor of adverse
outcome after STEMI,2 its invasive nature precludes
routine clinical use. Non-invasive estimates of diastolic
function, particularly Doppler assessment of LV filling
and, more recently, left atrial (LA) volume, have been
reported to be predictors of outcome following myocar-
dial infarction (MI).3 Previous studies have reported the
adverse impact of restrictive filling pattern (RFP) in
STEMI patients treated by thrombolysis, demonstrating
increased all-cause mortality.4 The present study evalu-
ated the impact of RFP on longer term outcomes in
STEMI patients treated by PCI. We hypothesised that RFP
would remain an independent predictor of longer term
outcomes in STEMI patients treated by PCI.
A total of 107 consecutive STEMI patients from Liver-
pool Hospital, Sydney (January 2003–May 2010), under-
went a transthoracic echocardiogram (TTE) (day 3–6
weeks), following STEMI. Patients were excluded for
atrial fibrillation (n = 3), severemitral regurgitation (n = 1)
and poor echocardiographic images (n = 3). A total of 100
patients (78males;mean age: 59 ± 11 years) comprised the
study group, andwas treated by rescue (n = 40) or primary
(n = 60) PCI. All patients were clinically stable when the
TTE was performed; none had an intra-aortic balloon
pump, were on inotropes or in heart failure (HF). All
participants had cardiac enzyme evaluation. The study
protocol was approved by the Sydney South West Area
Health Service ethics committee (QA2009/046).
A comprehensive echocardiogramwas performed using
commercial equipment (Phillips Sonos 7500, Philips Co,
The Netherlands; GE Vivid 7, Horten, Norway) according
to standard recommendations.5 Transmitral flow was
obtained from the apical four-chamber view using
pulsedDoppler, and peak E andAvelocities, E/A ratio, and
deceleration time (DT) were measured. Pulsed tissue
Doppler imaging (TDI) from the septal mitral annulus in
early diastole (e’) was evaluated when available (n = 59).
LV diastolic function was classified as normal, impaired
relaxation, pseudo-normal and restrictive filling based on
published criteria;5 RFP was defined as E/A ratio >2
and/or DT <140 ms.6 Patients (n = 10) with indeter-
minate diastolic grade (i.e. normal vs pseudo-normal
filling) were reviewed using A-wave and pulmonary
vein A-wave duration and e’ velocity. Left ventricular
ejection fraction (LVEF)7 was measured using the
modified biplane Simpson’s method; biplane maximum
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LA volume was measured using the area-length method;
and LV mass was calculated using the Penn method.8
The latter two variables were indexed to body surface
area.
Baseline demographic details, cardiac risk factors and
discharge medications were obtained from patient
records. Duration of ischaemia was measured from
symptom onset to establishing TIMI-3 flow. Clinical
outcomes, including cardiac death, all-cause death, HF
hospitalisation, non-fatal MI, stroke and coronary
revascularisation, were tracked for a median of 5 years,
from hospital records and/or by telephone follow up from
patients or their physicians. Major adverse coronary and
cerebral events were a composite of HF, death, MI, stroke
or revascularisation.
Analysis was performed using SPSS 19 (SPSS Inc.,
Chicago, IL, USA) and Stata 12 (StataCorp, College
Station, TX, USA). All statistical tests were two-tailed and
a P value <0.05 was deemed significant. Cumulative
survival was constructed by Kaplan–Meier curves, and
groups were compared with the log–rank test. A Cox
regression analysis was performed for the primary end-
point; variables significant at the bivariate level (P < 0.05)
or had clinical relevance were included in the model.
Multivariate logistic regression analysis was performed to
identify independent determinants of RFP.
The study cohort was stratified into restrictive (n = 24)
and non-restrictive (n = 76) groups (Table 1). A higher
proportion of patients treated with rescue PCI had RFP
(58% vs 34%, P = 0.035). Age, gender and cardiac risk
factors were similar. A significantly higher percentage in
the RFP group was discharged on loop diuretics and/or
aldactone (46% vs 19%, P = 0.011). Higher levels of
cardiac enzymes (TnT, CKMB and CK) were found in RFP
patients (P < 0.05 in all). E/A ratio was higher in RFP
patients (Table 1). TDI septal e’ velocitywas reduced in the
RFP group, but showed no significant difference. A signifi-
cantly larger indexed LA volume and a lower LVEF was
found in patientswith RFP than non-RFP group (43.2 ± 18
vs 35.8 ± 11 mL/m2, P = 0.017, and 41.4 ± 11.5% vs 48.7
± 8.7%, P = 0.001, respectively), whereas indexed LVmass
was similar between the groups (Table 1).
Kaplan–Meier analyses demonstrated that both cardiac
(1% vs 21%, P < 0.001) and all-cause death (9% vs 38%,
P = 0.003) were higher in RFP patients (Fig. S1). There
was no significant difference for other end-points
(Table S1). Cox regression analysis was performed to
investigate the predictive values of clinical and
echocardiographic indices on all-cause and cardiac death.
Variables included in the model were age, gender, PCI
(rescue vs primary), infarct-related variables (TnT, CK,
proximal LAD lesion and duration of ischaemia) and
echocardiographic indices (LVEF, indexed LV mass and
Table 1 Clinical characteristics and medications at discharge of STEMI
Non-RFP RFP P value
(n = 76) (n = 24)
Baseline characteristics
Age – year 61 ± 11 57 ± 10 0.14
Body mass index 28.4 ± 6.6 28.3 ± 4.8 0.90
Male (%) 58 (76) 20 (83) 0.47
Diabetes mellitus (%) 26 (34) 10 (42) 0.51
Prior AMI (%) 8 (11) 1 (4) 0.34
Prior stroke (%) 4 (5) 2 (8) 0.58
Heart failure (%) 2 (3) 1 (4) 0.70
Hypertension† (%) 46 (61) 13 (54) 0.58
Hyperlipidaemia‡ (%) 51 (67) 13 (54) 0.25
Current smoker (%) 46 (61) 12 (50) 0.36
Chronic kidney disease (%) 4 (5) 0 0.25
PCI indications
Primary (n = 60) 50 (66) 10 (42) 0.04
Rescue (n = 40) 26 (34) 14 (58)
Medication at discharge
Anti-platelets (%) 76 (100) 24 (100) ns
Beta-blockers (%) 61 (80) 20 (83) 0.74
Statins (%) 59 (78) 20 (83) 0.55
ARB/ACE inhibitors (%) 59 (78) 21 (88) 0.29
Diuretics (%) 15 (20) 12 (50) <0.01
Markers of infarct size
Peak troponin T – μg/L 6.3 ± 5.8 9.6 ± 8.2 0.04
Peak CKMB – μg/L 189 ± 191 312 ± 248 0.03
Peak CK – U/L 2011 ± 1821 4526 ± 4253 <0.001
Duration of ischaemia – hr 7.2 ± 5.8 8.0 ± 6.3 0.54
Culprit vessel – Prox LAD (%) 33 (43) 15 (63) 0.10
Echocardiographic characteristics
Time from STEMI to echo – days 7 ± 11 10 ± 14 0.32
Peak E-wave velocity – m/s 0.72 ± 0.19 0.84 ± 0.21 0.01
Peak A-wave velocity – m/s 0.68 ± 0.19 0.53 ± 0.20 0.001
E/A ratio 1.1 ± 0.3 1.9 ± 1.0 <0.001
E-deceleration time – ms 174 ± 35 132 ± 11 <0.001
DTI septal e’ – m/s ‡ 6.0 ± 2.1 5.3 ± 2.3 0.36
E/e’ ‡ 12.9 ± 5.6 22.4 ± 12.5 0.01
LA volume index – mL/m2 35.8 ± 11 43.2 ± 18 0.02
LVEF – % 48.7 ± 8.7 41.4 ± 11.5 0.001
LV mass index – g/m2 116 ± 32 114 ± 34 0.87
LVEDP – mmHg § 24.8 ± 8.0 30.5 ± 4.0 0.06
Mitral regurgitation grade
(mild-moderate)
4 (5) 2 (8) 0.58
Significant P values were displayed in bold. Data aremean ± SD or number
(percentage); †Arterial pressure>130/85 mm Hg or on anti-hypertensive
treatment; ‡Total cholesterol level ≥4.0 mmol/L or on lipid-lowering treat-
ment. ‡Data available in 59 patients; §Data available in 27 patients. ACE,
angiotensin-converting enzyme; AMI, acute myocardial infarction; ARB,
angiotensin receptor blocker; DTI, Doppler tissue imaging; E/A, early/late
diastolic velocity; e’, diastolic velocity; LAD, left anterior descending; LV,
left ventricular; LVEDP, left ventricular end diastolic pressure; LVEF, left
ventricular ejection fraction; RFP, restrictive filling pattern; STEMI,
ST-segment elevation myocardial infarction.
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LA volume). Only RFP and age were independent pre-
dictors of all-cause and cardiac death (Table 2). Inde-
pendent predictors of RFP determined by multivariate
logistic regression analysis (variables included were age,
gender, PCI indication, TnT, CK, proximal LAD lesion,
duration of ischaemia, LV mass index and LVEF) were CK
and LVEF (OR: 95% CI = 1.32: 1.07–1.62, P < 0.01, and
0.93: 0.87–0.99, P < 0.05, respectively).
This study evaluated the impact of RFP on long-term
outcomes in STEMI patients treatedwith PCI; RFP and age
were independent predictors of cardiac and all-causemor-
tality. Restrictive filling was more prevalent in rescue PCI
patients, those with higher cardiac biomarker levels, a
larger LA volume and a reduced LVEF. On multivariate
analysis, CK and LVEF were independent predictors of
RFP.
RFP has previously been identified as a predictor of
morbidity and mortality in acute myocardial infarction
patients.9 However, the majority of these reports, includ-
ing a meta-analysis from 2008,10 were performed in the
era of thrombolytic therapy where TIMI flow status was
not ascertained. Patients were heterogeneous, including
both STEMI and non-ST segment elevation myocardial
infarction patients. Follow up for the majority was 12–24
months, with only 3/16 studies having longer term
follow up (4 years). However, the current study examines
the impact of RFP in STEMI patients treated by contem-
porary PCI therapy, which has significantly improved
mortality and LVEF.11,12
The definition of RFP has been variable; some defined
RFP as E/A ratio >2, while others used a shortened DT.
We defined RFP as E/A ratio >2 and/or DT <140 ms in all
instances. Although current guidelines for the assessment
of LV diastolic function mandates more than E/A ratio
and DT, transmitral Doppler is robust for determining
RFP and has been used by other investigators, including
the MERGE HF group4 and the European Study Group on
Diastolic HF.13
Despite the modest size of the group and the low
number of events, patients with RFP had increased all-
cause and cardiac death. Multivariate analysis showed
stable numeric estimates for both hazards ratios and
95% CIs, with significance consistent with univariate
analyses results. A previous study demonstrated that RFP
at discharge was an independent predictor of mortality.14
Therefore, echocardiograms performed immediately
post-STEMI may reflect transient LV diastolic dysfunction
with subsequent improvement. In this study, as the
echocardiograms were performed at variable times (3
days−6 weeks), at worst, we would have underestimated
the likely effect of RFP after STEMI.
Approximately 30% of HF patients have preserved
LVEF and HF due to DD,15 with an increasing prevalence
with age.16 While RFP did not predict HF occurrence
(Table 2, P = 0.578), a higher percentage of RFP patients
were discharged on diuretics (Table 1). Cardiac bio-
markers (CK, CKMB and TnT) are surrogates of infarct
size.17–19 Significantly higher CK, CKMB and TnT levels
were observed in the RFP group, suggesting that a larger
infarct predisposed to the development of RFP. In a mul-
tivariate analysis, CK was an independent predictor of
RFP, similar to a previous study in STEMI patients that
demonstrated a correlation between peak CK and infarct
size.20
There are a several limitations given that this is a
single-centre retrospective study with an overall low
event rate; nevertheless, we believe our results are clini-
cally important and warrant further study. While the
timing of echocardiograms was variable, the percentage
of RFP (∼20%) was similar to that reported in other
studies.10 Patients with HT and diabetes may have pre-
existing DD; however, similar proportions of patients
with HT and DM were present in RFP and non-RFP
groups. We acknowledge that the modest cohort size
increases the likelihood of a type 2 error. However, the
weight of previous data on the adverse effects of RFP on
cardiac outcomes suggest that this is unlikely.
This study demonstrates that RFP was a determinant of
cardiac and all-cause mortality at a median follow up of 5
years post-STEMI treated by PCI. While the evaluation of
diastolic function following PCI for STEMI is an evolving
area, these preliminary results are interesting but require
validation in larger patient cohorts.
Table 2 Cox and risk multivariate model analyses
HR/OR 95% CI P value
Cox model: all-cause death
Age 1.13 1.04–1.22 <0.01
RFP 6.27 1.64–24.02 <0.01
Cox model: cardiac death
Age 1.25 1.01–1.53 <0.05
RFP 20.72 1.38–310.40 <0.05
Risk model: determinants of RFP
CK 1.32 1.07–1.62 <0.01
LVEF 0.93 0.87–0.99 <0.05
CI, confidence interval; CK, creatinine kinase; HR, hazard ratio, used in Cox
model; LVEF, left ventricular ejection fraction; OR, odds ratio, used in risk
model; RFP, restrictive filling pattern.
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Supporting information
Additional Supporting Information may be found in the online version of this article at the publisher’s web-site:
Figure S1 Cumulative incidence of outcomes among the study patients between RFP and non-RFP groups. Kaplan–
Meier survival curves are shown for (A) cardiac death; (B) all-cause death. P values were calculated using log–rank test.
Table S1 Clinical outcomes at 5 ± 2 years follow-up after index STEMI.
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